Jubilant Pharmova block deal: Quant Mutual Fund offloads Rs 190 crore stake amid Rs 800 crore fundraising plan; Abakkus buys 11 lakh shares

Quant Mutual Fund sold a total of 20.81 lakh shares of Jubilant Pharmova, valued at approximately Rs 190.47 crore, as the pharmaceutical company announced plans to raise up to Rs 800 crore through non-convertible debentures (NCDs), according to data from the National Stock Exchange (NSE) and BSE.

On the NSE, Quant Mutual Fund sold 11 lakh shares at Rs 915 apiece, valuing the transaction at Rs 100.65 crore. On the BSE, the fund sold another 9,81,704 shares at Rs 915.01 apiece, amounting to approximately Rs 89.82 crore, according to exchange data.

On the buying side, Abakkus Four2Eight Opportunities Fund purchased 11 lakh shares of Jubilant Pharmova at Rs 915 apiece, valuing the transaction at Rs 100.65 crore, according to NSE bulk-deal data.


Quant Small Cap Fund held 29,47,185 shares, representing a 1.85% stake in Jubilant Pharmova, as of June 30, 2026, according to shareholding data on the BSE. Assuming both reported sales came entirely from this holding, with no intervening changes in the fund's position, its holding would decline to 8,65,481 shares, or approximately 0.54% of the company.

At the closing price of Rs 950.90, the remaining 8,65,481 shares would be valued at approximately Rs 82.30 crore, subject to the stated assumption.

Shares of Jubilant Pharmova settled 2.04% higher at Rs 950.90 on the NSE, compared with the previous close of Rs 931.90. During the session, the stock traded in a range of Rs 908 to Rs 969.90. Despite Monday's gains, the counter has declined 8.80% so far in 2026, according to NSE data. The company's market capitalisation stood at Rs 15,146.04 crore.

ALSO READ: HCL Tech Q2 Results: Profit jumps 21% YoY to Rs 5,132 crore; co declares Rs 12/share dividend

Earlier today, Jubilant Pharmova informed the exchanges that its board had approved the issuance of up to 80,000 NCDs, with a face value of Rs 1 lakh each, aggregating up to Rs 800 crore. The securities will be issued on a private placement basis in one or more tranches, subject to applicable laws and regulatory approvals, if any.

The board also approved seeking shareholders' authorisation through a special resolution by postal ballot to issue non-convertible debt securities on a private placement basis, for an aggregate amount not exceeding Rs 2,500 crore outstanding at any point during the one year following the passing of the resolution.

Disclosure: This article has been written by Kumar Gaurav, who is not a Sebi-registered Research Analyst or an Investment Adviser. Gaurav and their ‘relative(s)’ (as defined under Section 2(77) of the Companies Act, 2013) do not hold any financial interest in the companies mentioned in this article as of the date of publication. The views/recommendations mentioned in this article, wherever applicable, are those of the respective Sebi-registered Research Analyst/brokerage and have been reproduced/reported with due attribution. They should not be construed as the views or recommendations of The Economic Times Digital or the journalist. Readers are advised to consider the original research report and make their investment decisions based on their own assessment. Brokerage disclaimers here